The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Webcast
Allen Archer, System Director of Supply Chain at Houston Healthcare, leads a thought-leader panel discussion about the role of GPOs within the chan
On-Demand Educational Webinars
Learn how to drive organizational and cultural improvements by utilizing cost, quality, and outcome data in the decision making process. This webinar…
On-Demand Educational Webinars
Hospitals need a tool to leverage the use of UDI within their health care organizations to empower the Cost, Quality, Outcomes Movement. This webinar…
Webcast
In part 2 of the GPO or Local/Self Contracting webcast series, the panel considers the multiple product categories and the process of choosing the
On-Demand Educational Webinars
Business continuity ensures that an organization can continue to operate in the event of a serious incident or disaster and encompasses strategic…